MRI Assessment of Patient Suitability for Cardiac Resynchronization Therapy (CRT)

Sponsor
NYU Langone Health (Other)
Overall Status
Suspended
CT.gov ID
NCT02728336
Collaborator
(none)
110
1
2
117
0.9

Study Details

Study Description

Brief Summary

The goals of this project are to: 1) explore the potential use of magnetic resonance imaging (MRI) data for improved prediction of response to cardiac resynchronization (CRT), and 2) use the MRI-derived data together with a computer model of the cardiovascular system to study the relative roles of different factors in the mechanical effects of dyssynchrony in failure, and in the response (or lack thereof) to CRT.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Cardiac MRI
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
110 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
MRI Assessment of Patient Suitability for Cardiac Resynchronization Therapy (CRT)
Actual Study Start Date :
Nov 1, 2014
Anticipated Primary Completion Date :
Aug 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Heart Failure Patients

patients who are scheduled to undergo clinically ordered CRT for heart failure complicated by dyssynchrony

Procedure: Cardiac MRI

Active Comparator: Control

20 matched control subjects

Procedure: Cardiac MRI

Outcome Measures

Primary Outcome Measures

  1. Derivation of score of patient suitability for CRT [4 Years]

    Binary logistic regression and receiver operating characteristic curve (ROC) analyses will be used to assess the utility of baseline (pre-CRT) MRI-derived measures, alone and in combination, for the prediction of response to CRT.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male and female patients ages 18 and over scheduled by conventional criteria (symptomatic impairment of cardiac function with broadened QRS) for clinical CRT procedures at NYULMC.

  • Normal kidney function as determined by GFR levels.

Inclusion Criteria for Controls

  • Normal kidney function as determined by GFR levels

  • No significant cardiovascular disease or risk factors.

Exclusion Criteria:
  • electrical implants such as cardiac pacemakers or perfusion pumps

  • ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants

  • ferromagnetic objects such as jewelry or metal clips in clothing (which will be removed)

  • pre-existing medical conditions including a likelihood of developing seizures or claustrophobic reactions, and any greater than normal potential for cardiac arrest.

Contacts and Locations

Locations

Site City State Country Postal Code
1 New York University School of Medicine New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: Leon Axel, MD, New York University Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT02728336
Other Study ID Numbers:
  • 14-01686
First Posted:
Apr 5, 2016
Last Update Posted:
Jul 7, 2022
Last Verified:
Jul 1, 2022

Study Results

No Results Posted as of Jul 7, 2022